Arab Board Anatomic Pathology Part 1 study materials
Arab Board Anatomic Pathology Part 1 study resources

Sudden collapse on day 8 postpartum: the autopsy before the ancillary results

Arab Board Anatomic Pathology Part 1 · Put your knowledge to work in context.

All case studies

Sudden collapse on day 8 postpartum: the autopsy before the ancillary results

A 29-year-old woman, gravida 2 para 2, collapses at home on day 8 after an uncomplicated vaginal delivery and is pronounced dead in the emergency department. Her body mass index is 36. At autopsy, 30 hours after death, the lungs are heavy and oedematous with no macroscopic thromboembolus. The uterus weighs 500 g with haemorrhagic decidua. The heart is 340 g with no gross fibrosis. There is an incidental 1.5 cm well-circumscribed thyroid nodule with papillary architecture and no capsular invasion. Histology is pending, and the family wants to know why she died. The death certificate must be issued today.

1. What is your differential for sudden collapse in this postpartum window, and which findings and ancillary tests separate the possibilities?

Read the worked answer

Differential and discriminating features:

  • Pulmonary embolism - the leading cause; pregnancy and obesity are major risk factors, and a normal macroscopical lung examination does not exclude thrombi in muscular pulmonary arteries. Look for organising or recent thrombus in small and medium vessels, and consider post-mortem CT pulmonary angiography if available.
  • Amniotic fluid embolism - usually intrapartum or within minutes of delivery, but delayed presentations are described; supported by fetal squames or mucin in pulmonary vessels (alcian blue/PAS, cytokeratin AE1/AE3, CD68 for trophoblast) with complement activation. Histology is insensitive and the diagnosis is clinicopathological.
  • Peripartum cardiomyopathy - histology is nonspecific, so the diagnosis is largely clinical and echocardiographic; the heart weight is not decisive here.
  • Eclampsia, sepsis/endometritis, pulmonary haemorrhage, aortic dissection and drug toxicity complete the list.

Ancillary tests to request: histology of lung (multiple blocks), myocardium, uterus and liver; special stains for squames; post-mortem blood cultures; toxicology; vitreous chemistry; and, if the family consents, post-mortem genetic testing for cardiomyopathy and channelopathy genes. A negative result must not be over-interpreted: lack of histological evidence does not exclude amniotic fluid embolism or a channelopathy.

2. How do you handle the 1.5 cm papillary thyroid nodule in the report and in your conversation with the family?

Read the worked answer

Classification: a 1.5 cm encapsulated papillary lesion without capsular or vascular invasion fits papillary thyroid microcarcinoma by size criteria (≤2 cm) if invasive features are absent; many such lesions are indolent, and some would now be classified as non-invasive follicular thyroid neoplasm with papillary-like nuclear features depending on architecture and borders. The final classification depends on the histology, which must be reported properly rather than mentioned in a footnote.

Placement in the death certificate: it must not appear in the cause-of-death line. It belongs in Part II ('other significant conditions contributing to death but not causally related'), framed as an incidental finding.

What to say to the family:

  • It did not cause the death, and it is very unlikely to have shortened her life.
  • It may have implications for first-degree relatives, so it should be documented and communicated to her next of kin and general practitioner.
  • If the histology later shows vascular invasion, extrathyroidal extension or nodal disease, revisit the assessment - but even then the lesion would not explain a sudden collapse at home.

Pitfall to avoid: listing the microcarcinoma as a 'contributing cause' because it is the only abnormality found. That error propagates into registries, distorts cause-of-death statistics and gives the family a false explanation.

3. The pathologist is asked to certify the cause of death today, before the histology returns. What do you write, and how do you manage the uncertainty?

Read the worked answer

Do not invent certainty. A death certificate is a legal document, but it can be amended, and an unsupported cause is worse than a provisional one.

What to enter: the anatomical findings and the leading clinicopathological diagnosis, worded so that the reasoning is visible - for example: 'Sudden death in the early postpartum period; autopsy shows pulmonary oedema and retained decidual tissue; findings consistent with a pregnancy-related cause, ancillary studies pending.' If a provisional certificate is permitted locally, mark it as provisional and state the tests outstanding.

What to avoid: certifying 'amniotic fluid embolism' or 'pulmonary embolism' before the evidence exists; certifying 'unascertained' when the autopsy has produced genuine leads; and allowing clinical pressure to convert a probability into a fact.

Manner of death: natural in this scenario unless toxicology or history indicates otherwise.

Communication plan:

  1. Tell the family what is known, what is being tested, and when the final report will be ready - in plain language, in a single conversation with a named contact.
  2. Issue an interim report to the clinical team and the coroner/medicolegal authority if the jurisdiction requires it.
  3. Set a defined date to review the ancillary results, and amend the certificate formally at that point rather than leaving two versions in circulation.

The most common failure here is silence: a family told nothing for eight weeks constructs its own explanation, and that explanation is rarely the right one.